What monitoring is recommended for metabolic risk in patients taking antipsychotics?

• A. Hair growth monitoring only
• B. Regular monitoring of weight/waist circumference, glucose, lipids; lifestyle interventions; choose agents with lower metabolic risk
• C. Do not monitor
• D. Urine glucose monitoring only

Answer: (C)

Monitoring metabolic risk is essential because many antipsychotics can trigger weight gain, insulin resistance, and dyslipidemia, which raise cardiovascular risk over time. The best approach combines regular checks of body measurements and labs with proactive lifestyle support. Specifically, track weight and waist circumference to catch weight gain early, screen for glucose abnormalities with fasting glucose or HbA1c, and assess lipids to detect dyslipidemia. Alongside these screenings, provide or refer for lifestyle interventions like nutrition counseling and physical activity, and when possible, choose antipsychotic agents associated with lower metabolic risk. This comprehensive plan enables early detection and management of metabolic issues, reducing long-term health consequences.

Hair growth monitoring doesn’t address metabolic risk and wouldn’t help manage cardiovascular concerns. Not monitoring at all would miss developing problems that could be treated or mitigated early, and relying on urine glucose alone would overlook weight changes and lipid abnormalities.